BPS In the Beltway | January 31, 2022 In Brief Annual Meeting: People or Projects? Approaches to Funding Research Annual Meeting: Beyond Coronavirus: Preparing for the Next Pandemic Justice Breyer’s Retirement offers Biden an Opportunity and a Presidential First Omnibus Talks Continue Between House and Senate Congressional Research Service (CRS) Delivers Report on FY22 Appropriations Tags: nihBPS Annual MeetingNational Institues of HealthOmnibusresearch fundingBPS in the BeltwayContinuing Resolution (CR)CoronavirusHouse Appropriations CommitteeCOVID-19Novel CoronavirusNational Science Foundation (NSF)Public Affairs Committee (PAC)Pandemic FundingFY22BPS Annual Meeting 2022BPS 2022Advanced Research Projects Agency for Health (ARPABurroughs Wellcome FundWellcome LeapHigh-Risk High-Reward ResearchPandemic PreparednesssPandemicUnited States Supreme CourtSupreme CourtSupreme Court of the United States (SCOTUS)Justice Stephen BreyerPresident Joe BidenFederal AppropriationsFY 2022Senate Appropriations CommiteeCongressional Research Service (CRS) Read more
BPS in the Beltway | August 13, 2020 In Brief Register for the 2020 Virtual Rally for Medical Research Make Policy Work for Science – Apply for the 2021-2022 BPS Congressional Fellowship The Latest on FY 2021 Appropriations Members of Congress, Ad Hoc Group Urge Support of NIH Emergency Funds FDA Vaccine Advisory Committee Tags: stemBPSRally for Medical ResearchRandy WadkinsCongressAppropriationsVaccinesresearch fundingBPS in the BeltwayNational Institutes of Health (NIH)Continuing Resolution (CR)BPS AdvocacyCOVID-19Public Affairs Committee (PAC)AAAS Science and Technology Fellowship ProgramBPS Congressional Fellowship ProgramLeah CairnsFY2021 BudgetPandemic FundingEmergency FundingRep. Katherine Clark (D-MA)Rep. John Moolenaar (R-MI)Sen. Jerry Moran (R-KS)Sen. Dick Durbin (D-IL)Ad Hoc Group for Medical ResearchFood and Drug Administration (FDA)Anthony FauciNational Institute of Allergy and Infectious DiseaCenter for Biologics Evaluation and Research (CBERVaccines and Related Biological Products Advisory Read more